Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"
06-01 Olympus Corporation acquired BioProtect Ltd. from Almeda Ventures Limited Partnership, Xenia Venture Capital Ltd, MVM VI, LP managed by MVM Partners LLP, Covidien Group S.à R.L. and Oriella Limited. CI
05-26 Olympus Corporation signed a definitive agreement to acquire BioProtect Ltd. from Almeda Ventures Limited Partnership, Xenia Venture Capital Ltd, MVM VI, LP managed by MVM Partners LLP, Covidien Group S.à R.L. and Oriella Limited for $270 million. CI
15/10/25 Omnix Medical Ltd. announced that it has received $25 million in funding from a group of investors CI
07/02/22 Xenia Venture Capital Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
04/10/21 COMSovereign Holding Corp. completed the acquisition of Saguna Networks Ltd. CI
31/08/21 Xenia Venture Capital Ltd Reports Earnings Results for the Half Year Ended June 30, 2021 CI
27/05/21 Olympus Winter & Ibe GmbH completed the acquisition of 81.5% stake in Medi-Tate Ltd from Xenia Venture Capital Ltd, P&T International Group, Ido Kilemnik and others for ¥ 28.4 billion. CI
18/05/21 COMSovereign Holding Corp. agreed to acquire Saguna Networks Ltd. for $12.1 million. CI
26/03/21 Xenia Venture Capital Ltd Reports Earnings Results for the Full Year Ended December 31, 2020 CI
26/02/21 Olympus Winter & Ibe GmbH entered into a letter of intent to acquire 81.5% stake in Medi-Tate Ltd from Xenia Venture Capital Ltd, P&T International Group, Ido Kilemnik and others for approximately ¥ 27.2 billion. CI
03/11/20 Omnix Medical Ltd. announced that it has received $8.5 million in funding from Xenia Venture Capital Ltd, Van Leer Xenia Ventures, The Office of the Chief Scientist CI
29/09/20 KeepMED Ltd. announced that it has received €13 million in funding from a group of investors CI
10/07/19 Centures Investment Limited cancelled the acquisition of an additional 5.4% stake in Xenia Venture Capital Ltd. CI
Manager TitleAgeSince
Chief Executive Officer 55 01/01/2017
Director TitleAgeSince
Director/Board Member 60 06/04/2006
Director/Board Member 53 08/05/2016
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 65.56M
+0.53%+1.55%+44.99%+0.71% 2.96B
+1.03%+1.29%-12.42%+5.96% 2.89B
+0.65%0.00%+36.42%+15.63% 2B
-2.53%-7.37%+99.39%+122.85% 1.3B
-3.09%-31.81%+324.50%+458.05% 1.05B
0.00%0.00%-1.72%-7.02% 723M
-7.69%-7.69%-49.30%-74.47% 431M
0.00%-1.34%-3.92%-7.55% 412M
0.00%0.00%-1.83%-10.79% 376M
Average -1.09%-2.22%+48.46%+55.93% 1.35B
Weighted average by Cap. -0.30%-0.76%+50.66%+53.24%
Logo Xenia Vc
Xenia Venture Capital Ltd is an Israel-based technology investment company. It is engaged in investing in early stage companies in the areas of high technology and medium technology in Israel. The Company also holds interest in Van Leer Xenia (VLX), a technological incubator operating under the incubator program of the Office of the Chief Scientist of the State of Israel (OCS). In addition to financing, the Company provides its companies with mentoring, business and strategic counseling, fund raising assistance and exit planning, as well as basic infrastructure and peripheral services, such as finance and accounting, logistics, and office support, among others. The Company mainly invests in companies in the areas of Information Technology (IT) and medical devices.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!